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Abstract Here we investigated the role of endogenous nitric 
oxide (NO) and peroxynitrite in the process of protein oxidation 
(as measured by the detection of 2,4-dinitrophenylhydrazine-
reactive carbonyls) in imiminostimulated macrophages. Immu-
nostimulation of the macrophages by bacterial lipopolysaccha-
ride and gamma-interferon (LPS/IFNy) resulted in a marked 
increase in the oxidation of a large number of mitochondrial and 
nuclear proteins. The inhibitor of NO synthase, NG-methyl-L-
arginine (3 mM), and the cell-permeable Superoxide dismutase 
mimetic Mn(III)tetrakis(4-benzoic acid)porphyrin (300 μΜ) 
both reduced the extent of protein oxidation in response to 
LPS/IFNy. These results support the view that endogenously 
produced peroxynitrite induces protein oxidation in the mito-
chondria and nucleus of immunostimulated macrophages. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The oxidation of cellular proteins in response to free-radical 
attack results from exposure to exogenous insults, such as 
ionizing radiation and environmental pollutants, and endoge-
nous toxins, produced during various physiologic processes 
[1,2]. In both instances, metalloenzymes catalyze the produc-
tion of highly toxic species which contribute to tissue injury 
and dysfunction. Oxidation of cellular proteins has been 
shown to be associated with aging and with various forms 
of inflammation [1,2]. 
Hydroxyl radical, produced from the metal-catalyzed reac-
tion of hydrogen peroxide and Superoxide is generally consid-
ered a major factor responsible for protein oxidation [1-4]. 
The chemistry of the hydroxyl radical-induced protein oxida-
tion has been extensively investigated [3,4]. 
Recent work has demonstrated that peroxynitrite, a reactive 
oxidant produced from the reaction of the free-radical nitric 
oxide (NO) with Superoxide anión, can initiate a variety of 
oxidative reactions [5-7], including the modification of nucleic 
acids, lipids, and proteins [5-7]. The production and reactions 
of peroxynitrite have generated much interest, because many 
pathophysiological conditions, including ischemia/reperfusion, 
arthritis, inflammatory bowel disease, and various forms of 
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circulatory shock are associated with the production of this 
oxidant [5-7]. Peroxynitrite has been proposed to be an im-
portant pathophysiological effector of tissue injury, mediating 
many of the cytotoxic effects previously attributed to NO. 
Many immunostimulated cells express an inducible isoform 
of NO synthase (iNOS). Large amounts of NO produced by 
iNOS have been suggested to mediate the cytotoxic/cytostatic 
effects of immunostimulated macrophages and other immune 
cells [8]. These conclusions were mainly based on studies in 
which NO production was inhibited by specific inhibitors of 
NOS, and, as a result, reduced cytotoxicity was observed [8,9]. 
However, more recent data suggest that the cytotoxic effects 
of immunostimulated macrophages are, at least in part, due to 
the production of peroxynitrite, which is produced from 
iNOS-derived NO and Superoxide in a variety of cell types 
including immunostimulated macrophages [10,11]. In addition 
to the cytotoxic/cytostatic effects towards extracellular and 
intracellular targets, immuno stimulation of macrophages, 
smooth muscle cells, and other cell types also results in a 
suppression of their own mitochondrial respiration, which 
can be blocked by NOS inhibitors [8-11]. Recent evidence 
supports the view that this autocrine cytotoxic effect is medi-
ated, at least in part, by endogenously produced peroxynitrite, 
rather than NO per se [12-15]. 
Exposure of various proteins to peroxynitrite can cause 
protein oxidation, as measured by an increase in the 2,4-dini-
trophenylhydrazine-reactive carbonyls in the proteins [16,17]. 
In the present study, we examined whether immunostimula-
tion of cultured macrophages also produces protein oxidation 
and have investigated the subcellular sites of protein oxidation 
in response to immunostimulation. Furthermore, by using 
NG-methyl-L-arginine (L-NMA), an inhibitor of NOS [8] 
and Mn(III)tetrakis(4-benzoic acid)porphyrin (MnTBAP), a 
cell-permeable Superoxide dismutase mimetic [18] and perox-
ynitrite scavenger [14] compound, we have attempted to char-
acterize the relative contribution of NO, Superoxide, and per-
oxynitrite to the protein oxidation in immunostimulated cells. 
2. Materials and methods 
2.1. Materials 
L-NMA monoacetate salt and MnTBAP were purchased from Cal-
biochem (La Jolla, CA). Sucrose was purchased from Boehringer-
Mannheim (Indianapolis, IN). Percoll was purchased from Pharmacia 
Fine Chemicals (Piscataway, NJ). SDS-PAGE gels and equipment 
were obtained from NOVEX (San Diego, CA). Chemiluminescent 
reagents were from Amersham (Arlington Heights, IL). Oxidized pro-
tein detection kit was purchased from Oncor (Gaithersburg, MD). 
Murine interferon-gamma (IFNy) was from Genzyme (Cambridge, 
MA). Tissue culture medium and fetal calf serum were from Gibco 
(Grand Island, NY). Bacterial lipopolysaccharide (E. coli, serotype 
No. Olli:B4) and all other reagents were obtained from Sigma (St. 
Louis, MO). 
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2.2. Cell culture and treatment conditions 
J774.2 mouse macrophages were cultured in DMEM medium with 
high glucose and supplemented with 10% fetal bovine serum. Cells 
were used at 80% confluence. For cultures involving stimulation with 
cytokines, heat-inactivated serum was used. Cells were treated with 
bacterial lipopolysaccharide (LPS, 10 μg/ml) and gamma-interferon 
(IFNy, 50 U/ml) in the presence or absence of L-NMA (3 mM) or 
MnTBAP (300 μΜ) for 6-24 h. 
2.3. Preparation of nuclear extracts 
Mininuclear extracts were prepared as described [19]. Briefly, cells 
were scraped and pellets resuspended in 400 μΐ of cold Buffer A 
(10 mM HEPES (pH 7.9), 10 mM KC1, 0.1 mM EDTA, 0.1 mM 
EGTA, 1 mM DTT, 0.5 mM PMSF, 1 μ^ιηΐ pepstatin A, 10 \i^Jm\ 
leupeptin] on ice for 15 min, followed by the addition of 25 μΐ of 1% 
NP-40. Then, samples were vortexed, centrifuged for 1 min at 
lOOOOXg, and the pellet resuspended with 100 μΐ of Buffer B 
(20 mM HEPES (pH 7.9), 400 mM NaCl, 1 mM EDTA, 1 mM 
EGTA, 1 mM DTT, 0.5 mM PMSF, 1 μ^piαΐ pepstatin A, and 
10 μg/ml leupeptin). After shaking on a rocker platform for 15 min 
4°C, samples were centrifuged for 15 min at lOOOOXg at 4°C. 
2.4. Preparation of mitochondria! fractions 
After 24 h in culture, cells were washed once with cold PBS, scraped 
in cold PBS, and centrifuged at lOOOOXg for 1 min in order to pellet 
the cells. PBS was removed by aspiration and the pellets were resus-
pended in 4 ml of 0.25 M sucrose, 1 mM EDTA, with 10 μg/ml 
leupeptin and 10 μg/ml pepstatin A. To enhance cell disruption, digi-
tonin in DMSO was added to the cell suspensions to a final concen-
tration of 0.10% and the cells were incubated on ice for 15 min, 
according to the method described by Moreadith and Fiskum [20]. 
The cell suspensions were then homogenized briefly in a hand-held 
glass homogenizer and centrifuged at 1300Xg for 5 min. The pellets 
were washed twice with 0.25 M sucrose, 1 mM EDTA and the washes 
added to the original supernatant. The post-nuclear supernatant was 
layered over a 'hybrid' Percoll: metrizamide discontinuous gradient as 
described by Madden and Storrie [21]. These gradients were prepared 
in polycarbonate tubes and centrifuged in a Beckman J2-HS centri-
fuge at 30000Xg for 30 min and the mitochondrial fraction isolated 
at the Percoll/17% metrizamide and the 17%/35% metrizamide inter-
faces and resuspended in PBS. 
2.5. Oxidized protein detection by SDS-PAGE and Western blotting 
For detection of oxidized proteins in whole cells, cells were scraped 
in PBS into microfuge tubes and centrifuged 14000Xg for 20 s. 
Supernatant was removed and 400 μΐ of RIPA lysis buffer with pep-
statin A (10 μΜ) and PMSF (0.5 mM) was used to resuspend the 
cells. RIPA buffer contains 1% Tergitol (Nonidet P-40), 0.5% sodium 
deoxycholate and 0.1% sodium dodecyl sulfate (SDS). DNA was 
sheared by repeated passage through a 22-gauge needle and the lysates 
incubated on ice 30 min. Cell lysates were then centrifuged in an 
Eppendorf 5402 centrifuge at 14000Xg for 30 min at 4°C. For the 
detection of oxidized proteins in nuclear fractions and mitochondrial 
fractions, fractions were separated as described above. 
The OxyBlot oxidized protein detection kit (Oncor, Gaithersburg, 
MD) was used to detect the carbonyl groups of protein side-chains 
caused by oxidation. Protein content was first determined by Bradford 
method (BIO-RAD, Melville, NY). Then, 5 μg of each sample was 
made to 5 μΐ with water and an equal volume of 12% SDS was added. 
10 μΐ of 2,4-dinitrophenylhydrazine was added and the reaction al-
lowed to proceed at room temperature for 15 min. Neutralization 
solution (7.5 μΐ, 0.74 M 2-mercaptoethanol) was added to stop the 
reaction. Cell lysates or cellular fractions which received no 2,4-dini-
trophenylhydrazine served as a negative control. 
The derivatized samples and standards were loaded onto pre-cast 
8-16% Tris/glycine mini gels and electrophoresed at 120 V for 2 h. 
The proteins were then transferred to nitrocellulose using the semi-dry 
method in isotachophoretic buffers at 15 V for 1 h. Membranes were 
then blocked with 1% bovine serum albumin (BSA) in PBS-T (0.05% 
Tween-20) for 1 h on an orbital shaker. The blocked membranes were 
then incubated with rabbit anti-DNP 1:150 in 1% BSA/PBS-T for 1 h, 
washed according to kit protocol, and incubated with goat anti-rabbit 
IgG-HRP 1:300 in 1% BSA/PBS-T for 1 h. The blots were washed as 
above and ECL chemiluminescent reagent added to the membrane for 
1 min. The blots were then exposed to X-ray film. When the results 
are presented as representative gels, results identical to the ones shown 
were obtained in experiments performed on at least three experimental 
days. 
3. Results 
3.1. Protein oxidation in response to immunostimulation: 
time-course 
There was a significant increase in the quantity of oxidized 
proteins at 24 h after exposure to the combination of LPS and 
IFNy. Some increase in the oxidations of proteins of approx-
imately 70 and 80 k D a were already detected at earlier time 
points (Figs. 1 and 2). However, at 24 h, a massive protein 
oxidation occurred. A significant port ion of the oxidized pro-
teins was found in the regions corresponding to molecular 
masses greater than 97 k D a (Figs. 1 and 2). 
3.2. Subcellular localization of oxidized proteins in 
immunostimulated cells 
Both in the mitochondrial fraction (Fig. 3) and in the nu-
clear fraction (Fig. 4) of immunostimulated cells, we have 
detected a marked increase in the oxidation of multiple pro-
teins after exposure of LPS and I F N . In control (unstimu-
lated) cells, there was also some protein oxidation of proteins 
of 50-60 k D a (Figs. 3 and 4). 
3.3. An inhibitor of NO synthase and a Superoxide dismutase 
mimetic inhibit protein oxidation in immunostimulated cells 
Inhibition of N O biosynthesis with the isoform-nonselective 
inhibitor L - N M A (3 m M ) significantly reduced the degree of 
protein oxidation in whole-cell homogenates (Fig. 1) and in 
mitochondrial and nuclear fractions (Figs. 3 and 4). Similar to 
the effect of L-NMA, the cell-permeable Superoxide dismutase 
mimetic M n T B A P (300 μΜ) reduced the extent of protein 
oxidation in immunostimulated cells, although its eifects, at 
this concentration, appeared to be somewhat less pronounced, 
in comparison to L - N M A (Figs. 1 and 2). 
Fig. 1. Detection of 2,4-dinitrophenylhydrazine-reactive (oxidized) 
proteins in homogenates of J774.2 macrophages immunostimulated 
with LPS and IFNy for 6, 12 or 24 h in the absence or presence of 
the NOS inhibitor L-NMA (3 mM). 
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4. Discussion 
The main findings of the current study are the following: 
immunostimulation of J774 cells results in a marked increase 
in protein oxidation[l]; protein oxidation occurs both in the 
nuclear and mitochondrial fractions[2]; protein oxidation is 
mitigated by inhibition of NOS with L-NMA[3]; protein ox-
idation is inhibited by MnTBAP, a Superoxide dismutase 
mimetic and peroxynitrite scavenger compound [4]. The re-
sults of the current study point towards the importance of 
endogenously produced peroxynitrite in the process of protein 
oxidation in immunostimulated macrophages. 
Protein oxidation is a ubiquitous post-translational modifi-
cation induced by a variety of physiological processes and 
noxious pathologic stimuli (see Section 1). The biological sig-
nificance of protein oxidation is determined by the function of 
the protein oxidized, the degree and nature of oxidation, and 
the physiological half-life of the modified protein. In the cur-
rent study, we did not attempt to identify specific proteins 
oxidized during immunostimulation. However, our data 
clearly demonstrate that protein oxidation occurs both in 
the nuclear and the mitochondrial fractions. It is conceivable 
that protein oxidation alters functionality [1-4]. For example, 
in respect to proteins important in the mitochondrial respira-
tory chain, it is well established that exposure to NO and 
peroxynitrite are able to reduce their activity [6,7,22,23]. 
The determination of the chemical nature of the endoge-
nous oxidant or oxidants responsible for protein oxidation 
in immunostimulated cells is of importance. Although bio-
chemical considerations suggest that NO is a weak oxidizing 
species [5-8], the marked protection against the protein oxi-
dation by the NOS inhibitor L-NMA in immunostimulated 
cells strongly suggests that a NO-related species is responsible 
for the oxidation of cellular proteins. A likely candidate may 
be peroxynitrite, which is a potent NO-derived oxidant. The 
protection against the protein oxidation afforded by both L-
NMA, and MnTBAP, a Superoxide dismutase mimetic and 
peroxynitrite scavenger or peroxynitrite decomposition cata-
lyst compound [14,18], further points towards the role of en-
Fig. 2. Detection of 2,4-dinitrophenylhydrazine-reactive (oxidized) 
proteins in homogenates of J774.2 macrophages immunostimulated 
with LPS and IFNy for 6, 12 or 24 h in the absence or presence of 
the Superoxide dismutase mimetic MnTBAP (300 μΜ). 
Fig. 3. Detection of 2,4-dinitrophenylhydrazine-reactive (oxidized) 
proteins in mitochondrial fractions of J774.2 macrophages immu-
nostimulated with LPS and IFNy for 24 h in the absence or pres-
ence of the NOS inhibitor L-NMA (3 mM). Control (C) on the left 
part of the gel indicates oxidized proteins in vehicle-treated cells 
and control on the right demonstrates the lack immunoreactivity in 
homogenates of immunostimulated cells in which 2,4-dinitrophenyl-
hydrazine was omitted from the reaction mixtures. 
dogenously produced peroxynitrite in the process. Many cy-
totoxic and oxidant processes in immunostimulated cells 
(inhibition of mitochondrial respiration, inhibition of mito-
chondrial and cytosolic aconitase, initiation of various types 
of DNA injury) are now believed to be due to the action of 
peroxynitrite rather than NO per se [6,7,22-24]. Some inves-
tigators have speculated that the production of peroxynitrite 
is relevant only if it occurs in the vicinity of mitochondria, 
because peroxynitrite does not travel sufficient distances with-
in the cell due to its rapid reaction with cellular thiols and 
carbohydrates [25]. The current data do not support this no-
tion, but suggest that proteins other than the ones within the 
mitochondria may also represent targets of endogenously pro-
duced peroxynitrite. 
Although the current method for the detection of oxidized 
proteins is being widely used by a large number of investiga-
tors [26,27], it may also detect other end-products of the per-
oxynitrite-cell interaction. One possibility is that the assay 
may detect protein-bound aldehyde end-products of lipid per-
oxidation [28], although this has not yet been demonstrated in 
relation to peroxynitrite-induced oxidant injury. A current 
study demonstrated marked protein oxidation in response to 
ischemia-reperfusion in a number of proteins in lung homo-
genates, which was reduced by inhibition of NO biosynthesis 
[29]. Since in that particular model of lung reperfusion injury, 
the same investigators have also provided evidence for the 
formation of peroxynitrite, and have suggested that peroxyni-
trite is responsible for the oxidant damage associated with 
reperfusion [29], it is reasonable to suggest that the protein 
oxidation during reperfusion also occurs, at least in part, due 
to peroxynitrite formation. Similar to the results of the cur-
rent study, also in the study in reperfused lung, the possibility 
that some of the detected protein oxidation is related to lipid 
peroxidation and aldehyde formation should be considered. 
One important difference between the current study and the 
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Fig. 4. Detection of 2,4-dinitrophenylhydrazine-reactive (oxidized) 
proteins in nuclear fractions of J774.2 macrophages immunostimu-
lated with LPS and IFNy for 24 h in the absence or presence of the 
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Peroxynitrite has been reported to cause a variety of protein 
modifications, including cysteine oxidation, t ryptophan oxida-
tion, tyrosine nitration, formation of protein carbonyls, dityr-
osine formation and protein fragmentation [6,7,16,17]. Recent 
studies have demonstrated the production of peroxynitrite in 
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and have proposed important roles for this oxidant in the 
associated tissue injury [5-7]. Fur ther studies will determine 
the biological significance of peroxynitrite as a mediator of 
various types of protein modifications in these conditions. 
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